Natco Pharma has announced the acquisition of a significant equity stake in South Africa-based Adcock Ingram, marking a strategic step to expand its global presence and diversify its pharmaceutical portfolio. The investment aims to strengthen Natco’s footprint in international markets, particularly in Africa, while leveraging Adcock Ingram’s established distribution network and product lines. The acquisition aligns with Natco’s long-term growth strategy of targeting high-potential emerging markets and therapeutic segments.
